Rina J. Jaju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rina J. Jaju has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
David Y. Mason
Leukaemia Research Fund Immunodiagnostic Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K
1 shared publication- Jacqueline Boultwood
University of Oxford, Oxford, United Kingdom
1 shared publication James S. Wainscoat
Leukaemia Research Fund Molecular Haematology Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K
1 shared publicationLyndal Kearney
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, U.K
1 shared publicationMargaret Jones
Leukaemia Research Fund Immunodiagnostic Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, U.K
1 shared publicationSusan Kelly
Department of Haematology, Wycombe General Hospital, High Wycombe, U.K
1 shared publication
Latest Publications
- 3 August 2000
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 29 (3) , 276-280
Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome
The 5q‐ syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory anemia, deletion of the long arm of chromosome 5, del(5q), as the sole cytogenetic abnormality, and a low frequency of transformation to acute leukemia. Using combined immunophenotyping and fluorescence in situ hybridization (FISH), studies were carried out on bone marrow smears of three 5q‐ syndrome cases to identify the cell lineages carrying the 5q deletion. In all three cases, the granulocytic, monocytic, and erythroid lineages possessed the del(5q) clonal marker, whereas the T‐lymphocytes did not. Interestingly, in one case, cells of B‐lymphoid lineage also showed the presence of the del(5q). This is the first report to date showing involvement of an acquired 5q deletion associated with MDS in B‐cells. This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells.
- 3 August 2000
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 29 (3) , 276-280
Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome
The 5q‐ syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory anemia, deletion of the long arm of chromosome 5, del(5q), as the sole cytogenetic abnormality, and a low frequency of transformation to acute leukemia. Using combined immunophenotyping and fluorescence in situ hybridization (FISH), studies were carried out on bone marrow smears of three 5q‐ syndrome cases to identify the cell lineages carrying the 5q deletion. In all three cases, the granulocytic, monocytic, and erythroid lineages possessed the del(5q) clonal marker, whereas the T‐lymphocytes did not. Interestingly, in one case, cells of B‐lymphoid lineage also showed the presence of the del(5q). This is the first report to date showing involvement of an acquired 5q deletion associated with MDS in B‐cells. This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells.